India to Zimbabwe: Pembrolizumab Export Trade Route
India has recorded 10 verified shipments of Pembrolizumab exported to Zimbabwe, representing a combined trade value of $163.5K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $16.3K USD. The leading Indian exporter is 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, which accounts for 58% of total export value with 7 shipments worth $94.3K USD. On the buying side, FOR THE ORDER OF is the largest importer in Zimbabwe with $54.3K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Zimbabwe Pembrolizumab corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $163.5K USD. The route is dominated by 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's pembrolizumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $16.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with pembrolizumab's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 25.5%, placing it at rank #18 among India's top pembrolizumab export destinations globally.
On the import side, key buyers of Indian pembrolizumab in Zimbabwe include FOR THE ORDER OF , FOR THE ORDER OF, FOR THE ORDER OF PEYTON KARIM and 2 others. FOR THE ORDER OF is the single largest importer with 2 shipments valued at $54.3K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#18
- Annual growth+25.5%
- Demand growth+23.3%
- Regulatory ease72/100
Top 10 Indian Pembrolizumab Exporters to Zimbabwe
Showing top 10 of 2 Indian suppliers exporting Pembrolizumab to Zimbabwe, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $13.5K per shipment | 7 | $94.3K | 57.7% |
| 2 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $23.1K per shipment | 3 | $69.2K | 42.3% |
This table shows the top 10 of 2 Indian companies exporting pembrolizumab to Zimbabwe, ranked by total trade value. The listed exporters are: 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED . 3S PHARMACEUTICALS INDIA PRIVATE LIMITED is the dominant supplier with 7 shipments worth $94.3K USD, giving it a 58% market share.
Top 10 Pembrolizumab Importers in Zimbabwe
Showing top 10 of 5 known buyers in Zimbabwe receiving Pembrolizumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pembrolizumab in Zimbabwe include FOR THE ORDER OF , FOR THE ORDER OF, FOR THE ORDER OF PEYTON KARIM, FOR THE ORDER OF PEYTON, FOR THE ORDER OF ....... . The largest importer is FOR THE ORDER OF , accounting for $54.3K USD across 2 shipments — representing 33% of all pembrolizumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FOR THE ORDER OF | 2 | $54.3K | 33.2% |
| 2 | FOR THE ORDER OF | 4 | $38.5K | 23.5% |
| 3 | FOR THE ORDER OF PEYTON KARIM | 2 | $37.3K | 22.8% |
| 4 | FOR THE ORDER OF PEYTON | 1 | $18.5K | 11.3% |
| 5 | FOR THE ORDER OF ....... | 1 | $14.9K | 9.1% |
Top 10 Pembrolizumab Formulations Imported by Zimbabwe
Showing top 10 of 8 product formulations shipped on the India to Zimbabwe Pembrolizumab route, ranked by trade value
Zimbabwe imports a wide range of pembrolizumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Pembrolizumab Injection Each Single Vial — accounts for $56.4K USD across 3 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Pembrolizumab Injection Each Single Vial | 3 | $56.4K | 34.5% |
| 2 | Pembrolizumab Injection Each Single VialContains 100mg of Pembrolizumab in 4 MLof Soluction 25mg/ml 1 PACK OF SIGLE V | 1 | $18.9K | 11.5% |
| 3 | Pembrolizumab Injection- Each Single Vial Contains 100mg of Pembrolizumab in 4 ML of Soluction 25mg/ml COO : Belgium Ba | 1 | $18.5K | 11.3% |
| 4 | PEMBROLIZUMAB INJECTION EACH SINGLE VIALCONTAINS 100 MG OF PEMBROLIZUMAB IN 4 ML OF SOLUTION25MG/ML | 1 | $18.5K | 11.3% |
| 5 | Pembrolizumab Injection- Each Single Via | 1 | $18.1K | 11.1% |
| 6 | Pembrolizumab Injection | 1 | $14.9K | 9.1% |
| 7 | Pembrolizumab Injection-Each Single Vial | 1 | $11.0K | 6.7% |
| 8 | Pembrolizumab Injection PACK SIZE : 1 PA | 1 | $7.2K | 4.4% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 71%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 7 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's pembrolizumab exports to Zimbabwe are driven primarily by a handful of large-scale manufacturers. 3S PHARMACEUTICALS INDIA PRIVATE LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Zimbabwe benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $16.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pembrolizumab injection each single vialcontains 100mg of pembrolizumab in 4 mlof soluction 25mg/ml 1 pack of sigle v and pembrolizumab injection- each single vial contains 100mg of pembrolizumab in 4 ml of soluction 25mg/ml coo : belgium ba, suggesting that buyers in Zimbabwe tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FOR THE ORDER OF is the largest importer with 2 shipments worth $54.3K USD — representing 33% of all pembrolizumab imports from India on this route.
Route Statistics
- Trade Volume
- $163.5K
- Avg. Shipment
- $16.3K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~16 days
- Annual Growth
- +25.5%
Related Analysis
Other Pembrolizumab Routes
Unlock the Full India to Zimbabwe Pembrolizumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 10 shipments on this route.
Frequently Asked Questions — India to Zimbabwe Pembrolizumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pembrolizumab to Zimbabwe?
The leading Indian exporters of Pembrolizumab to Zimbabwe are 3S PHARMACEUTICALS INDIA PRIVATE LIMITED, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED . 3S PHARMACEUTICALS INDIA PRIVATE LIMITED holds the largest market share at approximately 58% of total trade value on this route.
Q What is the total value of Pembrolizumab exports from India to Zimbabwe?
India exports Pembrolizumab to Zimbabwe worth approximately $163.5K USD across 10 recorded shipments. The average value per shipment is $16.3K USD.
Q Which ports does India use to ship Pembrolizumab to Zimbabwe?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 7 shipments. Indian exporters primarily use sea freight for this route, with 71% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Zimbabwe for Pembrolizumab?
The average transit time for Pembrolizumab shipments from India to Zimbabwe is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Zimbabwe Pembrolizumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.5% with demand growth tracking at 23.3%. The route is ranked #18 among India's top Pembrolizumab export destinations globally.
Q How many suppliers are active on the India to Zimbabwe Pembrolizumab route?
There are currently 2 active Indian suppliers exporting Pembrolizumab to Zimbabwe. The market is moderately concentrated with 3S PHARMACEUTICALS INDIA PRIVATE LIMITED accounting for 58% of total shipment value.
Q Who are the main importers of Pembrolizumab from India in Zimbabwe?
The leading importers of Indian Pembrolizumab in Zimbabwe include FOR THE ORDER OF , FOR THE ORDER OF, FOR THE ORDER OF PEYTON KARIM, FOR THE ORDER OF PEYTON, FOR THE ORDER OF ....... . FOR THE ORDER OF is the largest buyer with 2 shipments worth $54.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Zimbabwe export trade corridor identified from Indian Customs (DGFT) records for Pembrolizumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Zimbabwe matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 10 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
10 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists